United Health Products, Inc. Quarterly Debt-to-equity in % from Q3 2021 to Q3 2024

Taxonomy & unit
ratio: %
Description
Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary
United Health Products, Inc. quarterly Debt-to-equity history and growth rate from Q3 2021 to Q3 2024.
  • United Health Products, Inc. Debt-to-equity for the quarter ending September 30, 2024 was -110 %, a 7% increase year-over-year.
Debt-to-equity, Quarterly (%)
Debt-to-equity, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date
Q3 2024 -110 +8.31 +7% Sep 30, 2024
Q2 2024 -113 +6.93 +5.76% Jun 30, 2024
Q1 2024 -118 -3.72 -3.25% Mar 31, 2024
Q4 2023 -119 -7.1 -6.36% Dec 31, 2023
Q3 2023 -119 -10.1 -9.32% Sep 30, 2023
Q2 2023 -120 -12.5 -11.6% Jun 30, 2023
Q1 2023 -114 -1.95 -1.73% Mar 31, 2023
Q4 2022 -112 +20.3 +15.4% Dec 31, 2022
Q3 2022 -109 +32.3 +22.9% Sep 30, 2022
Q2 2022 -108 Jun 30, 2022
Q1 2022 -112 Mar 31, 2022
Q4 2021 -132 Dec 31, 2021
Q3 2021 -141 Sep 30, 2021
* An asterisk sign (*) next to the value indicates that the value is likely invalid.